Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H O Nguyen

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Communications Biology|May 10, 2020
Monocyte apoptotic bodies are vehicles for influenza A virus propagationGeorgia K Atkin-Smith, Mubing Duan, Damien J Zanker, et al.
Science Translational Medicine|February 16, 2018
Circulating T<sub>FH</sub> cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunityMarios Koutsakos, Adam K Wheatley, Liyen Loh, et al.
Nature Communications|April 29, 2024
CD8<sup>+</sup> T-cell responses towards conserved influenza B virus epitopes across anatomical sites and ageTejas Menon, Patricia T Illing, Priyanka Chaurasia, et al.
ACS Nano|June 27, 2022
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA VaccineYi Ju, Wen Shi Lee, Emily H Pilkington, et al.
EMBO Molecular Medicine|March 10, 2026
IFN-gene signatures in B cells following influenza A and B virus infection and influenza vaccinationWuji Zhang, E Kaitlynn Allen, Shihan Li, et al.
Immunity|March 23, 2023
SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responsesMarios Koutsakos, Arnold Reynaldi, Wen Shi Lee, et al.
Ebiomedicine|October 21, 2023
Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18-55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trialKeith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.
Elife|January 19, 2023
T follicular helper 17 (Tfh17) cells are superior for immunological memory maintenanceXin Gao, Kaiming Luo, Diya Wang, et al.
Open Forum Infectious Diseases|November 29, 2023
Evolution of Humoral and Cellular Immunity Post-Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-CilgavimabVictoria G Hall, Thi H O Nguyen, Lilith F Allen, et al.
Plos Pathogens|October 7, 2022
Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaquesBrendon Y Chua, Toshiki Sekiya, Marios Koutsakos, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Communications Biology|May 10, 2020
Monocyte apoptotic bodies are vehicles for influenza A virus propagationGeorgia K Atkin-Smith, Mubing Duan, Damien J Zanker, et al.
Science Translational Medicine|February 16, 2018
Circulating T<sub>FH</sub> cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunityMarios Koutsakos, Adam K Wheatley, Liyen Loh, et al.
Nature Communications|April 29, 2024
CD8<sup>+</sup> T-cell responses towards conserved influenza B virus epitopes across anatomical sites and ageTejas Menon, Patricia T Illing, Priyanka Chaurasia, et al.
ACS Nano|June 27, 2022
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA VaccineYi Ju, Wen Shi Lee, Emily H Pilkington, et al.
EMBO Molecular Medicine|March 10, 2026
IFN-gene signatures in B cells following influenza A and B virus infection and influenza vaccinationWuji Zhang, E Kaitlynn Allen, Shihan Li, et al.
Immunity|March 23, 2023
SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responsesMarios Koutsakos, Arnold Reynaldi, Wen Shi Lee, et al.
Ebiomedicine|October 21, 2023
Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18-55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trialKeith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.
Elife|January 19, 2023
T follicular helper 17 (Tfh17) cells are superior for immunological memory maintenanceXin Gao, Kaiming Luo, Diya Wang, et al.
Open Forum Infectious Diseases|November 29, 2023
Evolution of Humoral and Cellular Immunity Post-Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-CilgavimabVictoria G Hall, Thi H O Nguyen, Lilith F Allen, et al.
Plos Pathogens|October 7, 2022
Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaquesBrendon Y Chua, Toshiki Sekiya, Marios Koutsakos, et al.
Pageof 12